Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin Is Not Effective in Reducing Recurrent, Unexplained Miscarriages

Summary


To: NATIONAL EDITORS

Contact: Jane Woo, Fleishman-Hillard, +1-202-828-8922, jane.woo@fleishman.com, for American Society of Hematology; or Laura Stark, American Society of Hematology, +1-202-776-0544, lstark@hematology.org; Ernest N. Morial Convention Center (Dec. 4- 8): +1-504-670-7005

See the full content of this document

Extract


Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin Is Not Effective in Reducing Recurrent, Unexplained Miscarriages

NEW ORLEANS, Dec. 6 /PRNewswire-USNewswire/ -- Blood clotting, or coagulation, is an important process that prevents excessive bleeding when a blood vessel is injured. Sometimes, however, clots form on the inside of vessels without an obvious injury or do not dissolve naturally, a potentially life-threatening situation requiring treatment. Research presented today at the 51st Annual Meeting of the American Society of Hematology reveals that the practice of using the anticoagulants aspirin and heparin with the hope of preventing clots in placental blood vessels is ineffective for preventing unexplained, recurrent miscarr...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company